Intrahepatic cholestasis of pregnancy (ICP) cannot be reliably prevented. The condition results from a combination of genetic, hormonal, and environmental factors, and no proven strategy eliminates the risk. What you can do is understand your risk level, watch for early symptoms, and take steps that may reduce severity or improve outcomes if it develops.
Why Prevention Is So Difficult
ICP happens when the increased demands of pregnancy overwhelm the liver’s ability to process bile acids. In most people, the liver handles this extra load without trouble. But in those with certain genetic variants, the system breaks down. The largest genetic contributor is a gene called ABCB4, which helps move protective fats into bile to neutralize bile acids. Variants in this gene are found in up to 25% of women who develop ICP. Outside of pregnancy, these genetic differences usually cause no problems. The hormonal surge of pregnancy, particularly rising estrogen and progesterone levels in the third trimester, tips the balance.
Because the root causes are genetic and hormonal, there’s no supplement, diet, or medication that has been shown to prevent ICP from occurring in the first place. The focus instead shifts to early recognition, risk awareness, and managing the condition quickly once it appears.
Know Your Risk Factors
Some women are significantly more likely to develop ICP than others. If any of the following apply to you, discussing a monitoring plan with your provider early in pregnancy is the most practical “preventive” step you can take:
- Previous ICP. Recurrence rates range from 40% to 90% in the published literature. A recent single-center study found a recurrence rate of about 44%. Women whose bile acid levels exceeded 40 micromoles per liter in a prior pregnancy were especially likely to develop it again.
- Family history. A mother, sister, or other close relative with ICP increases your genetic susceptibility.
- Twin or multiple pregnancy. Carrying more than one baby increases the hormonal load on the liver.
- Underlying liver disease. Pre-existing liver conditions raise the risk.
- Gestational diabetes. This has also been linked to higher ICP rates.
If you’ve had ICP before, your provider can order bile acid blood tests earlier in your next pregnancy, before symptoms appear. Catching rising bile acid levels early allows treatment to start sooner, which improves outcomes for both you and the baby.
Vitamin D and Seasonal Patterns
Research has found a connection between low vitamin D levels and ICP. In one study, women with ICP had significantly lower vitamin D levels than pregnant women without the condition, averaging 8.6 versus 11.3 nanograms per milliliter. Lower vitamin D was also correlated with higher bile acid levels and more severe disease. ICP rates tend to be higher during winter months in some populations, which aligns with reduced sun exposure and lower vitamin D production.
This doesn’t prove that taking vitamin D prevents ICP, and no clinical trial has confirmed that supplementation reduces risk. But maintaining adequate vitamin D levels during pregnancy is already standard prenatal advice, and there’s reason to think it may matter more for women with other risk factors for ICP. Talk to your provider about checking your levels, particularly if you’re in a high-risk group.
Dietary Considerations
No specific diet has been proven to prevent ICP. However, if you develop the condition, dietary changes can help manage symptoms and prevent nutritional deficiencies. Cholestasis reduces your body’s ability to absorb fats properly, which can lead to digestive discomfort and deficiencies in fat-soluble vitamins.
A temporarily lower-fat diet, keeping fat intake under about 20 grams per day, can ease symptoms of fat malabsorption like pale stools and digestive upset. To prevent weight loss and ensure adequate calorie intake, medium-chain triglyceride (MCT) oils are often recommended as a fat substitute. These are absorbed differently than regular dietary fats and don’t require bile acids for digestion. The typical approach is to add MCT oil gradually, about one tablespoon per day, spread across meals to avoid stomach upset.
For women with significant fat malabsorption (noticeable as greasy or pale stools), vitamin K supplementation may be recommended. Vitamin K is a fat-soluble vitamin essential for blood clotting, and deficiency raises the risk of excessive bleeding after delivery. Your provider can check your clotting levels to determine whether supplementation is needed.
Early Symptom Recognition
Since you can’t fully prevent ICP, recognizing it early is the next best thing. The hallmark symptom is intense itching, typically on the palms of the hands and soles of the feet, that worsens at night. This itching usually begins in the third trimester but can start earlier. It feels different from the mild skin stretching or dryness of normal pregnancy. There’s generally no visible rash.
Other possible signs include dark urine, pale stools, mild jaundice (yellowing of the skin or eyes), fatigue, and loss of appetite. If you experience unexplained intense itching, request a bile acid blood test. Diagnosis is confirmed when total bile acids are elevated above normal. The condition is classified by severity: mild (19 to 39 micromoles per liter), moderate (40 to 99), and severe (100 or above).
Starting treatment before lab results come back, based on symptoms alone, is considered appropriate and can reduce risks. The primary treatment lowers bile acid levels and has been shown to reduce the risk of premature birth by over 40%, with the greatest benefit in severe cases.
What Happens After Diagnosis
Once ICP is diagnosed, your care team will monitor bile acid levels regularly and plan delivery timing based on severity. For mild ICP without other complications, the risk of stillbirth is not significantly increased, and delivery can proceed closer to your due date. For moderate cases, delivery between 36 and 39 weeks is typical. For severe cases with bile acids at 100 or above, delivery at 36 weeks is recommended because stillbirth risk rises around this time.
If delivery is planned before 37 weeks, you’ll likely receive corticosteroid injections to help the baby’s lungs mature. Continuous fetal monitoring during labor is recommended for severe and extremely severe cases.
Planning for a Subsequent Pregnancy
If you’ve had ICP and are planning another pregnancy, the recurrence rate is substantial but not inevitable. The 44% recurrence rate found in one large study means the majority of women did not experience it again. Interestingly, a shorter interval between pregnancies (less than 18 months from delivery to the next conception) was associated with lower odds of recurrence, though the reason for this isn’t fully understood.
Women whose bile acid levels stayed below 40 micromoles per liter in the first pregnancy had a much lower recurrence rate (about 7%) compared to those whose levels exceeded that threshold (about 30%). Knowing your previous bile acid peak can help your provider tailor a monitoring plan. Early and more frequent bile acid testing, starting in the second trimester, allows for faster intervention if levels begin to rise.